Sign up to save your podcasts
Or
Share CURE SYNGAP1 PODCAST aka SYNGAP10
Share to email
Share to Facebook
Share to X
Share to email
Share to Facebook
Share to X
Or
CURE SYNGAP1 PODCAST aka SYNGAP10
CURE SYNGAP1 PODCAST aka SYNGAP10 episodes
- What You Need to Know & When: DAY-C, UNLOCK, Ari, ORCA, HEOR, Denver (11 days to register) #S10E223
Tuesday, October 20, 2026 — Week 43
WHAT YOU CAN DO RIGHT NOW
- DAY-C remote developmental study — ages 9–25. Especially important for families who cannot participate in ProMMiS because travel/behavior makes in-person testing hard. [email protected] https://curesyngap1.org/blog/validating-remote-developmental-assessments-syngap1-related-disorders-grant-awarded-julie-orlando-center-for-epilepsy-and-neurodevelopmental-disorders-u-penn-jill-mckee-childrens-hospital-philadelphia/
- KNOW YOUR MUTATION. Join Citizen, ask Citizen; get Ari, ask Ari. ~70 families already using Ari. https://cureSYNGAP1.org/Ari
- COMBIOMICS — if Isaac or Grace from COMBINEDBrain emails you, respond. Very important study.
RAISE FUNDS VIA UNLOCK
- $200,000 matching gift!
- https://curesyngap1.org/calendar/unlock-their-tomorrow-2026-syngap1
COMING SOON — ORCA
- ORCA validation recruitment is coming. This is the most important survey to complete in Q4 if you want to help change the future.
TRAVEL
- Suzanne, Eric and I are off to BIO this week on Th/F.
- Next week Kathryn and I will be at the UK Conference followed by Edinburgh meetings.
- Kathryn will travel on to FAST where she and Virginie will partner and learn.
DENVER — REGISTER NOW
- Science Day: 204. Family Day: 168, including 32 kids/Syngapians. Registration closes OCT. 31. https://cureSYNGAP1.org/Reg26
- Rare Reception: https://cureSYNGAP1.org/RR26
- Family Dinner: 41 registered. https://cureSYNGAP1.org/Henrys
AT THE CONFERENCE → EARLY 2027 — HEOR
- HEOR kickoff happened. Family focus groups Thursday + Friday at the conference.
- Survey comes early 2027. This is patient-led research we need families to complete — data for payers, clinicians, behavior/anxiety burden and future access to treatment.
https://www.eurekalert.org/news-releases/1148569WHAT WE’VE BEEN UP TO
- Milken Institute Patient Advocacy Forum — “If it’s done right, it’s not done alone.”
- UT-Arlington — partnership discussions around how SYNGAP1 can be part of ambitious new work.
- Phoenix Children’s + COMBINEDBrain — Kathryn: partnership poised to “level up multidisciplinary care and clinical trial capacity.” Families + COMBINEDBrain helping bring patient expertise into trial planning. https://www.linkedin.com/posts/kathryn-syngap-research-fund_a-huge-thank-you-from-all-pediatric-rare-ugcPost-7515853296868229120-d0VM
- Theme: strategic collaboration — more institutions, more partners, more people doing the work.
SYNGAP1 AL DÍA
- New Spanish-language S10-style podcast hosted by Fernanda + Carlos Caparros of CURE SYNGAP1 LATAM. https://cureSYNGAP1.org/ALDia
SOCIAL MATTERS
5,333 LinkedIn. https://www.linkedin.com/company/cureSYNGAP1
1.63k YouTube. https://www.youtube.com/@CureSYNGAP1
Like + subscribe https://cureSYNGAP1.org/podcasts/syngap10
Episode 223 of #Syngap10 #SYNGAP1 #CureSYNGAP1 #Podcast #PatientAdvocacy
10 min - 1,871 #SYNGAP1 Census, COMBINEDBrain RR-RGND, Conference Dinner/Drinks & $200K Unlock Match #S10e222
Friday, October 2, 2026 — Week 40
CENSUS — 1,871 AND GROWING
- Q3 census: 1,871 known patients, +65 this quarter.
- First patient in Rwanda. USA +11, China +16, Brazil +6, France +4.
- Finding patients matters more than ever as trials approach. https://cureSYNGAP1.org/Census
COMBINEDBRAIN — RARE RESEARCH ROUNDTABLE
- Wonderful Rare Research Roundtable on Genetic Neurodevelopmental Disorders. COMBINEDBrain is a gift to the rare neuro community — hug them when you see them. https://combinedbrain.org/RR-RGND
- Dr. Emma James of Encoded, chair of our IAB, posted about the meeting. https://www.linkedin.com/posts/emma-james-71759a1a_the-combinedbrain-research-roundtable-on-ugcPost-7511223599165472768-jDkI
CURE SYNGAP1 CONFERENCE — DENVER
- 9 Family Legacy Sponsors, up from 8 in 2025.
- Thursday Rare Reception — free, register: https://cureSYNGAP1.org/RR26
- Friday Family Dinner at Henry’s: https://cureSYNGAP1.org/Henrys
- Conference registration ends OCT. 31. https://cureSYNGAP1.org/Reg26
UNLOCK THEIR TOMORROW
- Q4 goal: $500,000 by Dec. 31, including a $200,000 match.
- Families can start their own fundraiser; anyone can donate. https://cureSYNGAP1.org/Unlock
- Your Idea. Your Fundraiser. Your SYNGAP1 Impact. https://curesyngap1.org/blog/your-idea-your-fundraiser-your-syngap1-impact
COMMUNITY ACTION
- RARE Disease Week 2027, March 2-4, in DC. Travel reimbursement applications are open; deadline Nov. 6. https://bit.ly/4jo7fku
- RARE Foundation travel reimbursement post: https://www.facebook.com/share/p/1EeF8jTWFi
• Sign up for ARI: https://cureSYNGAP1.org/AriWARRIORS — JACK
- Jack is a 3-year-old from Berkeley who missed early milestones and was diagnosed with SYNGAP1 around age 3 after eyelid-fluttering episodes led to EEG, MRI and genetic testing. https://curesyngap1.org/syngap-warriors/jack-w
NEWSLETTER #52
- All the latest news and links in one place: https://cureSYNGAP1.org/NL52
- Subscribe: https://cureSYNGAP1.org/Newsletter
PUBMED + SCIENCE
- PubMed 2026: 54. +14 vs Week 40. https://pubmed.ncbi.nlm.nih.gov/?term=syngap1&filter=years.2026-2026&sort=date
USA - Use your ICD-10: F78.A1
SOCIAL MATTERS
5,301 LinkedIn. https://www.linkedin.com/company/cureSYNGAP1
1.63k YouTube. https://www.youtube.com/@CureSYNGAP1
11.0k X. https://twitter.com/cureSYNGAP1
43.4k Instagram. https://www.instagram.com/cureSYNGAP1
Like + subscribe wherever you listen. https://cureSYNGAP1.org/podcasts/syngap10
Episode 222 of #Syngap10 #SYNGAP1 #CureSYNGAP1 #Podcast #PatientAdvocacy
10 min - CAMP4 ASCEND Webinar + #SYNGAP1 Goes Global: Argentina, UN, Newborn Screening & Jaxon in ICU #S10E221
Saturday, September 26, 2026 — Week 39
CAMP4 ASCEND — WEBINAR #131
- SYNGAP1 ASCEND Phase 1/2 Trial: What You Need To Know.
- Monday, Sept. 28 — 12 PM PT / 3 PM ET / 19:00 UTC.
- Families: come hear directly from CAMP4 + ask your questions. https://cureSYNGAP1.org/AscendCT
ARGENTINA — PATH TO THE CLINICAL TRIAL
- CAMP4 + LATAM hybrid meeting: “Path to the Clinical Trial in Argentina.”
- Remember how they got here: THE CONFERENCE. Community → relationships → trial readiness.
- Recording: https://youtu.be/UuhOIzSEKH4
SYNGAP1 LEADERS REPRESENTING OUR COMMUNITY
- Incoming Board Chair Eric Moulton at Newborn Screening Bootcamp in DC. Critical that SYNGAP1 is involved in NBS — find patients sooner. Thank you RARE Foundation. https://www.rareadvocates.org/newborn-screening-bootcamp/
- Vicky Arteaga + Allison Hirsch represented CURE SYNGAP1 at Rare Diseases International at the UN. https://www.linkedin.com/posts/rare-diseases-international_unga81-rarediseases-globalhealth-activity-7508918814357610496-xtZS
WARRIORS
- Wednesday Warrior #237: Matteo in NYC — happy 1st birthday! https://cureSYNGAP1.org/Warrior
TAKE RESPIRATORY SERIOUSLY — JAXON IN ICU
- Aaron Harding documented Jaxon’s ICU experience day-by-day. A difficult family experience worth reading directly. Add serrapeptase to your regime.
- Aaron’s posts: https://www.facebook.com/aaron.j.harding.5
- Willsey paper: https://pmc.ncbi.nlm.nih.gov/articles/PMC11885846/ Another paper is coming soon.
COMMUNITY IN ACTION
- LATAM: One Voice for SYNGAP1 — VOCES! https://cureSYNGAP1.org/Voces
- Auburn Delta Sigma Phi + Wyatt Jones: Delta Sig for SYNGAP1. https://cureSYNGAP1.org/auburn26
CURE SYNGAP1 CONFERENCE — DENVER
- Dec. 3–4. Science Day: 156 registered. Family Day: 137, including 27 kids/Syngapians.
- REGISTRATION ENDS OCT. 31. Hotel rooms going fast — register + book now. https://cureSYNGAP1.org/Reg26
PUBMED + SCIENCE
- PubMed 2026: 54. +15 vs Week 39. Last year finished at 61, +9 vs the year. https://pubmed.ncbi.nlm.nih.gov/?term=syngap1&filter=years.2026-2026&sort=date
- NEW: Pekka Postila team — years of CURE SYNGAP1 support + partnership studying missense mutations.
- Molecular modeling supports canonical RasGAP + Plexin-like RapGAP mechanisms; missense variants can disrupt protein stability AND catalysis; other insights.
- Paper: https://doi.org/10.1016/j.yjsbx.2026.100162
USA: Use ICD-10 code F78.A1.
SOCIAL MATTERS
5,288 LinkedIn. https://www.linkedin.com/company/cureSYNGAP1/
1.62K YouTube. https://www.youtube.com/@CureSYNGAP1
11.1K X. https://twitter.com/cureSYNGAP1
43.7K Instagram. https://www.instagram.com/cureSYNGAP1/
Like + subscribe wherever you listen. https://cureSYNGAP1.org/podcasts/syngap10/
Episode 221 of #Syngap10 #SYNGAP1 #CureSYNGAP1 #Podcast #PatientAdvocacy
10 min - ASCEND Trial Webinar + #SYNGAP1 Warriors, Biobank, HEOR & Industry News #S10E220
Monday, September 21, 2026 — Week 39
CAMP4 ASCEND TRIAL — WEBINAR #131
- CAMP4’s SYNGAP1 ASCEND Phase 1/2 Trial — What You Need To Know.
- Tuesday, Sept. 29 — 12 PM ET / 9 AM PT.
- REGISTER https://curesyngap1.org/calendar/webinar-131-camp4-syngap1-ascend-phase-1-2-trial/
SCRAMBLE FOR SYNGAP — 12 DAYS
- 5th Annual — Oct. 3, Greer, SC.
- Julie + family back on WSPA 7 News — including some very real family moments.
- SOLD OUT. Five years of building awareness + community. https://youtu.be/GcD58deUPtU
- Event: https://cureSYNGAP1.org/Scramble
WARRIORS — KEEP TELLING THE STORIES
- NEW: Weston, 22 — diagnosed only 6 months ago. Late diagnosis! https://cureSYNGAP1.org/Warrior
- Will was Warrior #21 at age 9. He’s now 16. https://cureSYNGAP1.org/Will
- Kiera — Warrior #172 — now 6. https://cureSYNGAP1.org/Kiera
- These stories matter. Keep sharing them.
COMBINEDBrain BIOBANK — ONLY 2 LOCATIONS LEFT
- Boston — Oct. 8–9.
- Denver — Dec. 3–4 at the CURE SYNGAP1 Conference.
- Email [email protected].
HEOR — DOCUMENTING THE REAL BURDEN
- Building our Health Economics & Outcomes Research work with payers & clinicians in mind.
- Anxiety + behavior management matter.
- e.g. Rett: 323 caregivers — https://pubmed.ncbi.nlm.nih.gov/42570201/
- e.g. Angelman: U.S. study of 105 caregivers estimated average annual caregiving economic impact at $79,837 — 53% from employment impacts/lost productivity. https://pubmed.ncbi.nlm.nih.gov/39985061/
HELP WANTED — PRESS
- We have a backlog of CURE SYNGAP1 press releases.
- Know PR / communications? We need help.
- Volunteer skills matter just as much as fundraising.
IONIS — ANGELMAN
- Ionis published a community letter after the GTX-102/ASPIRE results.
- Relevant follow-up to my discussion in E217.
- Read it directly — 2’MOE https://assets.ctfassets.net/qj7dcdpo5rmb/nBQEr7TJQIyexzQu229Dl/a5ae4fff28861385532da0c8390b1c30/PA-US-AS-260005_-_Community_Statement_on_Status_of_Obudanersen_Program_-_FINAL_-_Sept_2026.pdf
ULTRAGENYX — CONGRATULATIONS
- FDA FULL APPROVAL for FAYUVI / UX111 for Sanfilippo syndrome Type A.
- First-ever FDA-approved treatment for MPS IIIA.
- Single-dose IV AAV9 gene therapy. Second approved gene therapy for RARE.
- https://ir.ultragenyx.com/news-releases/news-release-details/ultragenyx-announces-approval-fayuvitm-gene-therapy-first-ever
UPCOMING
SHOOT FOR SYNGAP1 — Nov. 14, Hurricane, UT https://cureSYNGAP1.org/Shoot
FIGHT FOR FELIPE — Nov. 28, Boston https://cureSYNGAP1.org/Fight
CURE SYNGAP1 CONFERENCE — Dec. 3–4, Denver https://cureSYNGAP1.org/Reg26
PUBMED
50 SYNGAP1 publications in 2026 — +11 vs. Week 39. https://pubmed.ncbi.nlm.nih.gov/?term=syngap1&filter=years.2026-2026&sort=dateUSA: Use your ICD-10, F78.A1
SOCIAL MATTERS
5,268 LinkedIn — +28 since E219. https://www.linkedin.com/company/curesyngap1
1.62k YouTube. https://www.youtube.com/@CureSYNGAP1
Like and subscribe wherever you listen. https://cureSYNGAP1.org/podcasts/syngap10
Episode 220 of #Syngap10 #RareDisease #CureSYNGAP1 #PatientAdvocacy
10 min - UK MHRA Approves CAMP4 ASCEND + USA Today + Rare-X/Citizen Health + 6 Things #S10E219
Friday, September 11, 2026 — Week 37
CAMP4 — ASCEND EXPANDS TO THE UK
- UK MHRA authorizes UK sites in CAMP4's Phase 1/2 CMP-002 trial.
- UK joins Australia + Argentina. EU filing remains under review.
- First-in-human trial still targeted to begin Q4 2026.
- Another major step toward our first disease-modifying clinical trial.
https://investors.camp4tx.com/news-releases/news-release-details/camp4-therapeutics-receives-authorization-united-kingdom-phaseCAMP4 ANALYST DAY — SEPT. 28
- 12–1:30 PM ET. Trial design + unmet need + early pipeline.
- CURE SYNGAP1 participating https://investors.camp4tx.com/news-events/events
- We will have a day after, webinar, stay tuned for details.
USA TODAY — SYNGAP1 IN PRINT
- SYNGAP1 family story appeared in USA TODAY's national print edition this week.
- Families need education, care + support TODAY.
https://www.usatoday.com/story/life/health-wellness/2026/09/01/kids-special-education-school-shortage-care/90851980007/RARE-X + CITIZEN HEALTH
- Global Genes selects Citizen Health technology to power RARE-X.
- Important for us: ProMMiS uses Rare-X; CURE SYNGAP1 already works with Citizen.
https://www.prnewswire.com/news-releases/global-genes-partners-with-citizen-health-to-power-rare-x-302870871.htmlSIX THINGS U.S. FAMILIES CAN DO
- Our Take Action page is LIVE.
- Don't just read it. Keep coming back until you've done all six.
https://curesyngap1.org/TakeActionIEP HELP — CITIZEN HEALTH
- Oct. 4: IEP deep dive + Q&A with Staci Zimmerman, M.Ed.
- Register https://curesyngap1.org/calendar/what-nobody-tells-you-about-ieps-citizen-health-webinar/
RESEARCH — HELP WANTED
- 2-year SYNGAP1 postdoc — Sapienza University of Rome.
- Patient iPSCs, cortical neurons + brain organoids.
- Deadline Sept. 30. Know someone? Amplify it. https://www.sins.it/job_offer/postdoctoral-position-available-at-sapienza-university-of-rome/
COMMUNITY QUICK HITS
- NEW WARRIOR: Felipe, age 3. Parents Brian + Alana organizing Fight for Felipe.
- Want to fundraise? New support form: https://cureSYNGAP1.org/Fundraise
- Café SYNGAP1 #40 + #41: GRIN2A + GRIN2B communities. https://cureSYNGAP1.org/Cafe
- Night of Impact recap live. Time to start planning the next one. https://cureSYNGAP1.org/SF26Recap
UPCOMING EVENTS — COUNTDOWN
SHOOT FOR SYNGAP1 — 64 DAYS
November 14 — Hurricane, UtahAiming for a Cure — Shooting for Hope https://cureSYNGAP1.org/ShootFIGHT FOR FELIPE — 78 DAYS
November 28 — Boston, Massachusetts https://cureSYNGAP1.org/FightCURE SYNGAP1 CONFERENCE — 83 DAYS
December 3–4 — Denver, Colorado https://cureSYNGAP1.org/Reg26USA 🇺🇲: Use your ICD-10, F78.A1
SOCIAL MATTERS
5,240 LinkedIn — https://www.linkedin.com/company/curesyngap1
1.62k YouTube https://www.youtube.com/@CureSYNGAP1
43.7k Instagram https://www.instagram.com/curesyngap1
Like and subscribe to this podcast wherever you listen. https://curesyngap1.org/podcasts/syngap10
Episode 219 of #Syngap10 #SYNGAP1 #RareDisease #CureSYNGAP1 #PatientAdvocacy
10 min - USA Today, Synchrony Conf, #EEC2026, Portugal & Family Resources — #CureSYNGAP1 in Action #S10E218
Tuesday, September 8, 2026 — Week 37
DON’T MISS ASO UPDATEEpisode 217 came out over the weekend. Don't miss it. There was lots of ASO news in there.https://www.linkedin.com/feed/update/urn:li:activity:7502544874399928322/NATIONAL PRESSUSA TODAY Special-needs care / education crisis — and a SYNGAP1 family featured. Diagnosis and future therapies aren't enough. Families need care, education and support today.
https://www.linkedin.com/posts/bernadette-basilico-6924b29a_a-two-year-postdoctoral-position-with-share-7500493855591432192-sOD6/https://www.usatoday.com/story/life/health-wellness/2026/09/01/kids-special-education-school-shortage-care/90851980007/ADVOCACY UPDATESYNCHRONY — PALO ALTO
KAH + I attended the BRAIN Foundation's Synchrony symposium.
The autism community is starting to wake up to neuroinflammation, and mental health psychiatrists are really working hard on this topic. There are also people looking more at the impact of diet. https://brainfoundation.org/synchrony-symposia/
ILAE #EEC2026 — ATHENS
Virginie + Jaime + Vicky + Katrine representing SYNGAP1 at the 16th European Epilepsy Congress, Sept. 5–9. https://www.ilae.org/eec2026
Virginie’s Post: https://www.linkedin.com/posts/virginie-mcnamar_eec2026-ugcPost-7502600886368559105-LPbu/THINGS YOU CAN DO RIGHT NOW
- GENEDX SURVEY
How has getting a SYNGAP1 diagnosis improved your child's care?
5 minutes. Worth it. Please do it. https://curesyngap1.org/GDXsurvey
- ARI / CITIZEN HEALTH
Sign up. Longitudinal medical records → research-ready data.
This is clearly the future. https://citizen.health/ari/syngap1
- SYNGO
SYNGAP1 resource for families from LATAM, ask it to speak English! https://curesyngap1.org/syngo
COMMUNITY GROWTH AND SUCCESSCURE SYNGAP1 PORTUGAL 🇵🇹
Congratulations to the Portuguese SYNGAP1 community — legal organization established + website live.
Special applause for Henrique’s leadership. Another national organization building local advocacy and community. https://curegyngap1-portugal.org/en
SCRAMBLE FOR SYNGAP — SOLD OUT
Congratulations to the Scramble team — the 5th Annual Scramble for SYNGAP is SOLD OUT.
25 days to go. A great example of a community building momentum year after year. https://mailchi.mp/796f3e59d71b/the-scramble-for-syngap-is-sold-out?e=b5a3afc6ba
UPCOMING EVENTS — COUNTDOWN
SHOOT FOR SYNGAP1 — 67 DAYS
November 14 — Hurricane, Utah
Aiming for a Cure — Shooting for Hope https://cureSYNGAP1.org/ShootFIGHT FOR FELIPE — 81 DAYS
November 28 — Boston, Massachusetts https://cureSYNGAP1.org/Fight
CURE SYNGAP1 CONFERENCE — 86 DAYS
December 3–4 — Denver, Colorado https://cureSYNGAP1.org/Reg26
PUBMED50 SYNGAP1 publications in 2026. +13 vs. Week 37. https://pubmed.ncbi.nlm.nih.gov/42692765/
Last year finished at 61 publications — +9 vs. the year. https://pubmed.ncbi.nlm.nih.gov/?term=syngap1&filter=years.2026-2026&sort=date
USA 🇺🇲: Use your ICD-10, F78.A1
SOCIAL MATTERS5,220 LinkedIn — https://www.linkedin.com/company/curesyngap1
1.61k YouTube https://www.youtube.com/@CureSYNGAP1
11.1k X https://x.com/cureSYNGAP1
43.7k Instagram https://www.instagram.com/curesyngap1
Like and subscribe to this podcast wherever you listen. https://curesyngap1.org/podcasts/syngap10
Episode 218 of #Syngap10 #SYNGAP1 #ASO #AngelmanSyndrome #AlexanderDisease #RareDisease #CureSYNGAP1 #PatientAdvocacy
10 min - #Angelman ASO Fails, #AlexanderDisease ASO Wins: #SYNGAP1 CAMP4 ASO? NYT on Clinical Trials #S10E217
Sunday, September 6, 2026 — Week 36
🛑 If you're reading this on social media, these show notes are going to get cut off. Please go to the podcast homepage and click on episode 217 to get the full show notes. https://curesyngap1.org/podcasts/syngap10
ALEXANDER DISEASEOn September 3, the FDA approved ZANVASTRO — zilganersen — from Ionis (IONS) for Alexander disease.
It is the first FDA-approved treatment for Alexander disease and the first therapy to directly target the underlying protein buildup driving the disease. Alexander disease is caused by mutations in GFAP. Zilganersen reduces production of abnormal GFAP protein.
https://www.fda.gov/news-events/press-announcements/fda-approves-first-drug-treat-alexander-disease
ANGELMAN — ULTRAGENYX ASPIRE FAILSOn September 2, Ultragenyx (RARE) announced results from its Phase 3 Aspire trial of apazunersen, formerly GTX-102, for Angelman syndrome.
The trial failed its primary endpoint — change from baseline in Bayley-4 cognitive raw score. It also failed its key secondary endpoint — the Multidomain Responder Index, or MDRI. And there were no differences between the treated and control groups supporting efficacy in Bayley cognition, the MDRI, or any of the five individual domains that make up the MDRI.
https://ir.ultragenyx.com/news-releases/news-release-details/ultragenyx-announces-phase-3-aspire-results-angelman-syndrome
WHAT HAPPENED?Financial analyst take on the failure was brutal: “A complete double miss, with no data to argue about.”
But this does not conclude that the underlying Angelman ASO strategy has been disproven. Broader read-through: “We think the mechanism still works, and the constraint was dose.” GTX-102 had a history of transient lower-extremity weakness.
OAK HILL BIO (RACC) BASICALLY CALLED IT(Good to have multiple shots on goal.)
Look at slides 10 and 11 of Oak Hill Bio's July investor presentation filed with the SEC.
Oak Hill had already been making the case that the Angelman ASOs are not interchangeable.
On slide 10, Oak Hill presents primate data showing nearly full restoration of paternal UBE3A production after a single dose of rugonersen, versus a much more modest reported effect from GTX-102. Importantly, Oak Hill itself notes that this was not a head-to-head study.
Then look at slide 11. Oak Hill presents data claiming rugonersen is 20–100 times more potent at inducing UBE3A protein than the other Phase 3 Angelman ASOs. And its description of the Ultragenyx molecule is remarkably direct: “GTX-102 was dose limited.”
These are Oak Hill's claims and company-presented preclinical data — but they made this argument before Aspire failed.
https://www.sec.gov/Archives/edgar/data/2118032/000119312526316954/d101725dex992.htm
THIS IS WHY PHASE 3 MATTERSUltragenyx had encouraging earlier-stage data. Families appeared to be seeing improvements. Investigators saw improvements. The company saw improvements. Then came a randomized, sham-controlled Phase 3 trial. And it did not confirm efficacy.
That is an important lesson for all of us in rare disease drug development:
Phase 1/2 data are not Phase 3 data.THE NEW YORK TIMES — GETTING TO A CLINICAL TRIAL IS HARDThere was also a New York Times piece this week that I think everyone following drug development should read.
How extraordinarily difficult it has become to actually run clinical trials and get experimental medicines into patients.
That means companies are looking outside the United States for places where trials can move more efficiently.
CAMP4 has regulatory clearance to begin its first-in-human SYNGAP1 trial in Australia and Argentina.
That's not an accident. The geography of clinical drug development is changing.
The New York Times article is largely looking at this through the lens of cancer drug development today — but rare genetic disease is confronting the same challenges.
Cancer today → rare genetic disease tomorrow. — read this article.
NEW YORK TIMES — GIFT LINK:
https://www.nytimes.com/2026/09/04/opinion/clinical-trials-drugs-science.html?unlocked_article_code=1.-lA.gxCw.n2L6DEBVdtFd&smid=nytcore-ios-share
ANGELMAN COMMUNITY IS A MODELOne more thing. A failed Phase 3 trial is devastating for a patient community.
AB https://www.linkedin.com/feed/update/urn:li:share:7501449189785022464/TJB https://www.linkedin.com/feed/update/urn:li:activity:7501404380412145665/UPCOMING EVENTS — COUNTDOWNSCRAMBLE FOR SYNGAP — 27 DAYS
October 3 — Greer, South Carolina
5th Annual Scramble for Syngap https://cureSYNGAP1.org/ScrambleSHOOT FOR SYNGAP1 — 69 DAYS
November 14 — Hurricane, Utah
Aiming for a Cure — Shooting for Hope https://cureSYNGAP1.org/ShootFIGHT FOR FELIPE — 83 DAYS
November 28 — Boston, Massachusetts https://cureSYNGAP1.org/Fight
CURE SYNGAP1 CONFERENCE — 86 DAYS
December 3–4 — Denver, Colorado https://cureSYNGAP1.org/Reg26
PUBMED50 SYNGAP1 publications in 2026. +14 vs. Week 36. The newest publication comes from a team in India. https://pubmed.ncbi.nlm.nih.gov/42692765/
Last year finished at 61 publications — +9 vs. the year. https://pubmed.ncbi.nlm.nih.gov/?term=syngap1&filter=years.2026-2026&sort=date
USA 🇺🇲: Use your ICD-10, F78.A1
SOCIAL MATTERS5,219 LinkedIn — +24 since Episode 216. https://www.linkedin.com/company/curesyngap1
1.61k YouTube https://www.youtube.com/@CureSYNGAP1
11.1k X https://x.com/cureSYNGAP1
43.7k Instagram https://www.instagram.com/curesyngap1
Like and subscribe to this podcast wherever you listen. https://curesyngap1.org/podcasts/syngap10
Episode 217 of #Syngap10 #SYNGAP1 #ASO #AngelmanSyndrome #AlexanderDisease #RareDisease #CureSYNGAP1 #PatientAdvocacy
10 min - Big Week for #SYNGAP1: Trials, Data, #Epilepsy, Palo Alto & Athens #S10E216
Sunday, August 30, 2026 — Week 36
TRIALS & DATA — CAMP4, RARE-X + ProMMiSCAMP4 / CMP-002- Australia and Argentina cleared.
- EU and UK filings underway.
- First-in-human Phase 1/2 study still targeted for Q4 2026.
- CMP-002 is designed to increase expression of the healthy SYNGAP1 copy.
- CAMP4 raised another $50M and reports cash runway through the end of 2028.
- Q2 earnings / corporate update:
https://investors.camp4tx.com/news-releases/news-release-details/camp4-reports-second-quarter-2026-financial-results-andRare-X + ProMMiS- Rare-X is our PRO partner for the ProMMiS Natural History Study.
- IMPORTANT: Families participating in ProMMiS need to complete their Rare-X surveys within SEVEN DAYS of their ProMMiS Natural History Study visit date.
- We need the patient/caregiver-reported data to line up with the clinical visit data.
ProMMiS: https://curesyngap1.org/resources/studies/syngap1-prommis/
Rare-X: https://cureSYNGAP1.org/RAREX
ARI WEBINARIf you missed the Ari webinar, the recording is now available. https://cureSYNGAP1.org/AriWeb
FUNDRAISE WITH USPlease call us to set up your fundraisers. Please do not use Facebook fundraising unless it's an emergency.
CURE SYNGAP1 ON THE ROAD — BRAIN FOUNDATIONKathryn and I are attending the BRAIN Foundation’s Synchrony 2026 scientific summit in Palo Alto.
A chance for CURE SYNGAP1 to stay close to work happening across autism, neurology, genetics, biomarkers and therapeutics. https://brainfoundation.org/synchrony-symposia/
ILAE — EUROPEAN EPILEPSY CONGRESSVirginie is heading to Athens for the 16th European Epilepsy Congress, September 5–9.
If you are going to be at the ILAE meeting in Athens, Greece, reach out to Virginie and connect with CURE SYNGAP1 in person. https://www.ilae.org/eec2026
UPCOMING EVENTS — COUNTDOWNSCRAMBLE FOR SYNGAP — 34 DAYS
October 3 — Greer, South Carolina5th Annual Scramble for Syngaphttps://cureSYNGAP1.org/ScrambleSHOOT FOR SYNGAP1 — 76 DAYS
November 14 — Hurricane, UtahAiming for a Cure — Shooting for Hopehttps://cureSYNGAP1.org/ShootFIGHT FOR FELIPE — 90 DAYS
November 28 — Boston, Massachusettshttps://cureSYNGAP1.org/FightCURE SYNGAP1 CONFERENCE — 95 DAYS
December 3–4 — Denver, ColoradoEarly bird pricing ends August 31!https://cureSYNGAP1.org/Reg26PUBMEDPubMed 2026 is at 49. +2 since Episode 214. +13 vs. the week. Last year finished at 61, +9 vs. the year.
https://pubmed.ncbi.nlm.nih.gov/?term=syngap1&filter=years.2026-2026&sort=dateCoolest new paper: TBE on EEG. https://pubmed.ncbi.nlm.nih.gov/42620081/USA 🇺🇲: Use your ICD-10, F78.A1
SOCIAL MATTERS5,195 LinkedIn. +36 since Episode 214. https://www.linkedin.com/company/curesyngap1
1.61k YouTube. https://www.youtube.com/@CureSYNGAP111.1k Twitter https://twitter.com/cureSYNGAP143.7k Insta https://www.instagram.com/curesyngap1Like and subscribe to this podcast wherever you listen. https://curesyngap1.org/podcasts/syngap10
Episode 216 of #Syngap10 #SYNGAP1 #CureSYNGAP1 #Podcast #PatientAdvocacy
10 min - #AdamsCamp & Tony in Denver: Support, Progress & Open Issues, taking a break from #LakeMary #S10e215
Tony with us for a week after five months away…
- Way less screen addicted
- More independent
- Chubby - Less exercise, worse food
- Depressed
Adam’s Camp was great as usual
- The support model was striking: the camper-to-therapist ratio was close to one-to-one, with skilled professionals in speech, occupational, physical, and behavioral therapy.
- SYNGAP1 Connection at Camp!
- This was Tony’s fifth consecutive year at https://adamscamp.org/.
- That continuity made a difference. The Adam’s Camp team knew Tony well, and he was a known quantity to them.
- The team did a fabulous job. Even though Tony can be challenging at this age, and is bigger and sometimes aggressive, everything went smoothly at camp.
More time in Denver.
- We visited Dr. Abbott at CHOC.
- For families looking for pediatric dental support in Denver, see Dr. Z at https://www.lakesidekidsdentistry.com/. Who will also start seeing kids at https://www.childrenscolorado.org/doctors-and-departments/departments/dental/
The hard parts
There were still a couple of moments of aggression within our family. I do not want to pretend those moments disappeared; there is more work to do.
The harder news came after Tony returned to school. His unhappiness about being there has increased after being with family, and it feels as though aggression may be moving in the wrong direction again. We are told this kind of transition is common for kids at his school, but that does not make the incident reports any less heartbreaking.
Bringing him back was heartbreaking. Lorazepam.
Open Questions
What stayed with me is how well Tony did with people who knew him and a deeply skilled team supporting him. At his residential program, he also receives remarkable support. But at the end of the school year, he is expected to come home, and we are expected to recreate enough of that support with ABA and whatever additional help we can find.
I do not have a neat conclusion. I am trying to understand what is best for Tony, what is best for John, and what is best for our whole family. I am sharing these questions because I suspect many families carry versions of them too.
Related episodes & resources
- For the earlier Adam’s Camp conversation, watch #S10e110 https://www.youtube.com/watch?v=WBBEZPLRaBQ
- For the residential-care update, watch #S10e208 https://www.youtube.com/watch?v=ywDUuuGA8GA
- For a fuller personal conversation about this chapter in Tony’s life, listen to https://curesyngap1.org/podcasts/syngap1-stories/mike-graglia-may-2026-update
- Learn more about https://lakemary.org/.
- Both the Adam’s Camp team and Dr. Z from Lakeside will have a booth at the CURE SYNGAP1 Conference in Denver on December 3–4. Stop by to learn more and meet the team. https://curesyngap1.org/calendar/cure-syngap1-conference-2026-denver/
Like and subscribe to the CURE SYNGAP1 Podcast wherever you listen. https://curesyngap1.org/podcasts/syngap10
Saturday, August 29, 2026 — Week 35
Episode 215 of #Syngap10 #SYNGAP1 #CureSYNGAP1 #Podcast #PatientAdvocacy
#Caregiving #DisabilitySupport #FamilyCaregiver #CaregiverSupport10 min - Go Ada & Ford. Fundraise now. #CTRPoll Do it now. Porter’s Sib Story. ORCA Study soon! #S10e214
Monday, August 10, 2026 - Week 33
Make sure to watch #S10e213 first! https://www.linkedin.com/posts/curesyngap1_camp4-trial-approved-in-australia-argentina-activity-7491598254027984896-wWTg
145 done! Out of 516 in US per last census: (https://www.linkedin.com/posts/curesyngap1_syngap1census-syngap1-census-activity-7478070129340215296-6Hjx)CLINICAL TRIAL READINESS SURVEY - http://curesyngap1.org/CTRpoll
Do it now, let us figure out the state of our community.
CITIZEN Sign up now! https://www.citizen.health/ai-advocate/syngap1
Everyone with a sick kid needs this.
Different from CONNECT: https://curesyngap1.org/curesyngap1connect
Make sure we know how to reach you.
STUDIES ARE HAPPENING- Albus, thank you to those families. Plug it in.
- Combi[o]mics - Thank you for doing this if invited.- Everyone will get an invite to do an ORCA Validation Study, please do this. If you don’t get that email by end of August, bug us. We are only inviting those we can confirm have a mutation.PERSONAL FUNDRAISERS
Fundraisers advance our mission & help you connect to community#ForAda curesyngap1.org/forada is over $104k of $10k
#4Ford curesyngap1.org/4ford is over $20k of $20k
SIBLINGS - Go Porter!
cureSYNGAP1.org/SiblingTHINGS TO LOOK FORWARD TO…
5TH SCRAMBLE FOR SYNGAP, SC – 54 days till October 3rd
Classic case of a small event becoming an institution! cureSYNGAP1.org/Scramble26
SHOOT FOR SYNGAP, UT – 96 days till November 14th
curesyngap1.org/calendar/shoot-for-syngap1
FIGHT FOR FELIPE, MA - 111 days till November 29th
curesyngap1.org/Fight26
CURE SYNGAP1 CONFERENCE - 115 days until December 3rd & 4th
cureSYNGAP1.org/Reg26 rooms available: cureSYNGAP1.org/denhyatt for $159. In on Wed, out on Saturday.
PUBMED
Pubmed 2026 is at 47. +14 vs the week. (61 last year was +9) We are already at the 3rd highest year. https://pubmed.ncbi.nlm.nih.gov/?term=syngap1&filter=years.2026-2026&sort=date
USA 🇺🇲: Use your ICD-10, F78.A1
SOCIAL MATTERS
5,159 LinkedIn. https://www.linkedin.com/company/curesyngap1
1.6k YouTube. https://www.youtube.com/@CureSYNGAP1
11.1k Twitter https://twitter.com/cureSYNGAP1
43.7k Insta https://www.instagram.com/curesyngap1
Like and subscribe to this podcast wherever you listen. https://curesyngap1.org/podcasts/syngap10
Episode 214 of #Syngap10 #SYNGAP1 #CureSYNGAP1 #Podcast #PatientAdvocacy
10 min
About CURE SYNGAP1 PODCAST aka SYNGAP10
From the publisher's feed
Over 1,600 families are caring for a loved one with the rare disease ”SynGAP” resulting from a variant of the SYNGAP1 gene. This weekly podcast is for them. -A quick summary of the latest news in…
the space. The host is Mike Graglia, co-founder & managing director of CURE SYNGAP1. CURE SYNGAP1 is a parent-led public charity in the US that strives to accelerate research into treatments for SYNGAP1 so that we can help our loved ones in a timeframe that matters. Learn more at https://cureSYNGAP1.org
More shows like CURE SYNGAP1 PODCAST aka SYNGAP10
Armchair Expert with Dax Shepard
69,495 Listeners
SYNGAP1 Stories
29 Listeners
Café SYNGAP1
19 Listeners